REQUEST A DEMO
Total
USD $0.00
Search more companies

Implemedica Dotaciones Hospitalarias S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Implemedica Dotaciones Hospitalarias S.A.S. Profile Updated: February 20, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Implemedica Dotaciones Hospitalarias S.A.S. is an enterprise in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on March 21, 2018. 4 (2022) employees currently work for Implemedica Dotaciones Hospitalarias S.A.S.. In 2021, the company reported a net sales revenue increase of 21.83%. Its total assets grew by 45.72% over the same period. The net profit margin of Implemedica Dotaciones Hospitalarias S.A.S. increased by 0.31% in 2021.

Headquarters
Calle 25 # 69D-51 Torre 3 Of.412
Bogota D.C.; Bogota D.C; Postal Code: 0615

Contact Details: Purchase the Implemedica Dotaciones Hospitalarias S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Implemedica Dotaciones Hospitalarias S.A.S. report to view the information.
Outstanding Shares:
Purchase the Implemedica Dotaciones Hospitalarias S.A.S. report to view the information.
Incorporation Date:
March 21, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Implemedica Dotaciones Hospitalarias S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
21.83%
Total operating revenue
21.83%
Operating profit (EBIT)
10.76%
Net Profit (Loss) for the Period
29.89%
Total assets
45.72%
Total equity
12.93%
Operating Profit Margin (ROS)
-0.73%
Net Profit Margin
0.31%
Return on Equity (ROE)
1.5%
Quick Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?